FULTRESSE

Serial Number 98846759
686

Registration Progress

Application Filed
Nov 11, 2024
Under Examination
Approved for Publication
Jun 3, 2025
Published for Opposition
Jun 3, 2025
Registered

Basic Information

Serial Number
98846759
Filing Date
November 11, 2024
Published for Opposition
June 3, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jun 3, 2025
Application
Pending
Classes
005

Rights Holder

Taro Pharmaceuticals U.S.A., Inc.

03
Address
3 Skyline Drive
Ste 120
Hawthorne, NY 10532

Ownership History

Taro Pharmaceuticals U.S.A., Inc.

Original Applicant
03
Hawthorne, NY

Taro Pharmaceuticals U.S.A., Inc.

Owner at Publication
03
Hawthorne, NY

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

13 events
Date Code Type Description
Jun 3, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 PUBO A PUBLISHED FOR OPPOSITION
May 28, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 5, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2025 GNRT F NON-FINAL ACTION E-MAILED
Feb 5, 2025 DOCK D ASSIGNED TO EXAMINER
Feb 5, 2025 CNRT R NON-FINAL ACTION WRITTEN
Nov 11, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 11, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Medicated dermatological preparations and substances; Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, circulatory, dermatological, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmic, psychiatric and viral diseases and disorders; Pharmaceutical preparations for the treatment of alopecia, blood disorders, bone growth disorders, skin disorders, sleep disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives

Classification

International Classes
005